Literature DB >> 4879882

The actions of caerulein on gastric secretion of the dog and the rat.

G Bertaccini, R Endean, V Erspamer, M Impicciatore.   

Abstract

1. Caerulein, as expected from its amino-acid composition and sequence, has a potent stimulant action on gastric secretion in the dog, the rat and the frog.2. In the denervated fundic pouch of the dog, caerulein increases the rate of flow of gastric juice and the outputs of acid and pepsin. Acid concentration and pepsin concentration in caerulein-produced juice are generally greater than in control juice. The threshold subcutaneous dose of caerulein is 0.15-0.5 mug/kg and the threshold rate of intravenous infusion 0.25-0.5 mug/kg per hr. Rapid intravenous injection is ineffective. On a molar basis, caerulein is approximately twice as active as human gastrin I on volume and acid output of the gastric pouch and 4 times as active on pepsin output.3. Sustained acid secretion of the fundic pouch produced by histamine infusion is inhibited by caerulein, administered either intravenously or subcutaneously. In turn, acid secretion elicited by caerulein is inhibited by atropine.4. In the rat, the activity ratio of caerulein to human gastrin I is 7-30, calculated on a molar basis, and is thus considerably greater than in the dog. Further, caerulein is 3 times more active than cholecystokinin-pancreozymin. Tested on the perfused stomach preparation of the rat, the threshold dose of caerulein by rapid intravenous injection is 25 ng/kg, by intravenous infusion 0.25 mug/kg per hr, and by subcutaneous injection 0.25 to 0.5 mug/kg.5. The activity of caerulein is sharply reduced by pretreatment of the rats with the histamine liberator 48/80 and potentiated by pretreatment with the diamine oxidase inhibitor aminoguanidine. When caerulein is given by rapid intravenous injection during a priming infusion of histamine its effect is enhanced and considerably prolonged.6. The isolated mucosa of the frog stomach is extremely sensitive to caerulein which, in a concentration of a few pg/ml., stimulates active transport of chloride.7. Qualitative and quantitative differences in the action of gastrin and caerulein are pointed out, and particular emphasis is laid on the importance of esterification of the tyrosyl residue for the biological activity of caerulein.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4879882      PMCID: PMC1703331          DOI: 10.1111/j.1476-5381.1968.tb07053.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  14 in total

1.  Effect of pancreozymin preparations on gastric secretion.

Authors:  A R Cooke
Journal:  Nature       Date:  1967-05-13       Impact factor: 49.962

2.  Gastric secretion of rats after test meals.

Authors:  S Antonsen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1965

3.  Histidine decarboxylase inhibition and gastric secretion.

Authors:  W R Thayer; H F Martin
Journal:  Am J Dig Dis       Date:  1967-10

4.  Synthetic peptides related to caerulein. 1.

Authors:  A Anastasi; L Bernardi; G Bertaccini; G Bosisio; R De Castiglione; V Erspamer; O Goffredo; M Impicciatore
Journal:  Experientia       Date:  1968-08-15

5.  Isolation and amino acid sequence of caerulein, the active decapeptide of the skin of hyla caerulea.

Authors:  A Anastasi; V Erspamer; R Endean
Journal:  Arch Biochem Biophys       Date:  1968-04       Impact factor: 4.013

6.  The action of caerulein on the systemic arterial blood pressure of some experimental animals.

Authors:  G Bertaccini; G De Caro; R Endean; V Erspamer; M Impicciatore
Journal:  Br J Pharmacol Chemother       Date:  1968-05

7.  Effect of acetazolamide and cholecystokinin on the secretion of pepsin from histamine-stimulated Heidenhain pouches.

Authors:  P Heitmann; A M Jungreis; H D Janowitz
Journal:  Gastroenterology       Date:  1967-02       Impact factor: 22.682

Review 8.  Some aspects of gastric secretion.

Authors:  M I Grossman
Journal:  Gastroenterology       Date:  1967-05       Impact factor: 22.682

9.  Isolation of aspartyl-phenylalanine amide from cholecystokinin-pancreozymin.

Authors:  V Mutt; J E Jorpes
Journal:  Biochem Biophys Res Commun       Date:  1967-02-21       Impact factor: 3.575

10.  The actions of caerulein on the smooth muscle of the gastrointestinal tract and the gall bladder.

Authors:  G Bertaccini; G De Caro; R Endean; V Erspamer; M Impicciatore
Journal:  Br J Pharmacol       Date:  1968-10       Impact factor: 8.739

View more
  19 in total

Review 1.  Cyclic AMP and gastric secretion.

Authors:  M S Amer
Journal:  Am J Dig Dis       Date:  1972-10

2.  The action of caerulein on gastro-intestinal propulsion in mice.

Authors:  D Piccinelli; F Ricciotti; A Catalani; P Sale
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

3.  Action of caerulein and caerulein-like peptides on "short-circuit current" and acid secretion in the isolated gastric mucosa of amphibians.

Authors:  L Negri; V Erspamer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

4.  On the ability of caerulein to increase propulsive activity in the isolated small and large intestine.

Authors:  G M Frigo; S Lecchini; C Falaschi; M Del Tacca; A Crema
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

Review 5.  Progress report: caerulein.

Authors:  V Erspamer
Journal:  Gut       Date:  1970-01       Impact factor: 23.059

6.  The actions of bombesin on gastric secretion of the dog and the rat.

Authors:  G Bertaccini; V Erspamer; M Impicciatore
Journal:  Br J Pharmacol       Date:  1973-11       Impact factor: 8.739

7.  Effects of tetraprenylacetone on pancreatic exocrine secretion and acute pancreatitis in two experimental models in rats.

Authors:  I Tachibana; N Watanabe; H Shirohara; T Akiyama; S Nanano; M Otsuki
Journal:  Int J Pancreatol       Date:  1995-04

8.  Gastrin release by bombesin in the dog.

Authors:  G Bertaccini; V Erspamer; P Melchiorri; N Sopranzi
Journal:  Br J Pharmacol       Date:  1974-10       Impact factor: 8.739

9.  Discrepancies between the doses of cholecystokinin or caerulein-stimulating exocrine and endocrine responses in perfused isolated rat pancreas.

Authors:  M Otsuki; C Sakamoto; H Yuu; M Maeda; S Morita; A Ohki; N Kobayashi; K Terashi; K Okano; S Baba
Journal:  J Clin Invest       Date:  1979-03       Impact factor: 14.808

10.  Effects of cannabinoid receptor agonists on rat gastric acid secretion: discrepancy between in vitro and in vivo data.

Authors:  Gabriella Coruzzi; Maristella Adami; Elena Guaita; Alessandro Menozzi; Simone Bertini; Elena Giovannini; Giulio Soldani
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.